COHR.NYSECoherent CORP

Form 4: Coherent Corp. President Walter Robert Bashaw II Executes Stock Option and Sells Shares Under 10b5-1 Plan

Sentiment:

SEC Form 4


Walter Robert Bashaw II, President of Coherent Corp., exercised stock options and sold 19,195 shares of common stock on June 3, 2024, according to a Form 4 filing with the SEC.

Summary

  • On June 3, 2024, Walter Robert Bashaw II, President of Coherent Corp., executed options to acquire 14,820 shares of common stock at a price of $27 per share.
  • Simultaneously, Bashaw sold 14,820 shares at $70 and 4,375 shares at $67.3752, totaling 19,195 shares sold.
  • These transactions were executed under a pre-arranged Rule 10b5-1 trading plan adopted on December 14, 2023.
  • Following these transactions, Bashaw directly owns 99,659 shares of Coherent Corp. common stock.
  • He also indirectly owns 80 shares through children and 1,400 shares through a spouse.

Sentiment

Score: 5

Explanation: The sentiment is neutral as it reports routine transactions under a pre-existing trading plan. There's no indication of positive or negative implications for the company's performance.

Industry Context

This filing is a routine disclosure of insider transactions. It's common for executives to utilize 10b5-1 plans to sell shares over time to avoid accusations of trading on inside information. The impact on the stock price is usually minimal unless the transactions are unusually large or frequent.

Comparison to Industry Standards

  • Executive compensation packages often include stock options, and it's standard practice for executives to periodically exercise these options and sell shares.
  • The use of Rule 10b5-1 trading plans is a common method employed by corporate insiders to manage their stock holdings and avoid potential insider trading concerns, similar to practices seen at companies like Lumentum and IPG Photonics.

Stakeholder Impact

  • The transactions may have a minor dilutive effect on existing shareholders due to the exercise of stock options.
  • The sale of shares could exert slight downward pressure on the stock price, although the impact is likely to be minimal given the pre-planned nature of the transactions.

Key Dates

DateDescription
June 27, 2019Date of Power of Attorney execution.
December 14, 2023Date of adoption of Rule 10b5-1 trading plan.
June 3, 2024Date of stock option exercise and share sales.
June 4, 2024Date of signature of the Form 4 by Attorney-in-Fact.
November 5, 2026Expiration date of options.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.